Sign inGet started

Burkhardt Glen

Insider CIK 1803271 · PHAS VP, Human Resources

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PHAS PhaseBio Pharmaceuticals I S Sale2022-05-232022-05-2411,248$0.79 $8.9K0SEC↗
PHAS PhaseBio Pharmaceuticals I A Award2022-05-202022-05-2411,248$0.68 $7.6K11,248SEC↗
PHAS PhaseBio Pharmaceuticals I A Award deriv2022-02-242022-02-2887,500— $087,500SEC↗
PHAS PhaseBio Pharmaceuticals I A Award deriv2022-02-242022-02-2818,750— $018,750SEC↗
PHAS PhaseBio Pharmaceuticals I A Award2021-11-192021-11-235,766$2.01 $11.6K5,766SEC↗
PHAS PhaseBio Pharmaceuticals I S Sale2021-11-192021-11-235,766$2.37 $13.7K0SEC↗
PHAS PhaseBio Pharmaceuticals I S Sale2021-05-202021-05-243,811$3.29 $12.5K0SEC↗
PHAS PhaseBio Pharmaceuticals I A Award2021-05-202021-05-243,811$2.80 $10.7K3,811SEC↗
PHAS PhaseBio Pharmaceuticals I A Award deriv2021-02-052021-02-0936,000— $036,000SEC↗
PHAS PhaseBio Pharmaceuticals I S Sale2020-11-232020-11-233,497$3.45 $12.1K0SEC↗
PHAS PhaseBio Pharmaceuticals I A Award2020-11-202020-11-233,497$3.00 $10.5K3,497SEC↗
PHAS PhaseBio Pharmaceuticals I A Award deriv2020-02-122020-02-1420,000— $020,000SEC↗
PHAS PhaseBio Pharmaceuticals I A Award deriv2020-02-122020-02-1455,000— $055,000SEC↗